Filters

Calbindin 1 (AF2E5) Monoclonal Antibody

Calbindin 1 (AF2E5) Monoclonal Antibody size: 0.1ml 362

Price 362
Size 0.1ml
Long nameCalbindin 1 (AF2E5) Monoclonal Antibody
Also known asCalbindin 1 (AF2E5) Monoclonal Antibody
CategoryPrimary Antibodies
ConjugationUnconjugated
Target AntigenCalbindin1
SpecificityThis is a highly specific antibody against Calbindin1
Modification(s)None
Modification site(s)Unmodified antibody
ClonalityMonoclonal
Clone numberAF2E5
Concentration1ug per 1ul
SourceRecombinant human protein purified from E, coli (His-Calbindin1)
Gene ID number793
Swiss ProtP05937
Tested ApplicationsWB
Recommended dilutions000), WB (1:2
Cross reactivity Mouse, Rat, Human
Cross reactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Background of the target antigen May stimulate a membrane Ca(2+)-ATPase and a 3', 5'-cyclic nucleotide phosphodiesterase, Buffers cytosolic calcium
Purification methodPurified by Protein G
Storage conditions 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA
Synonym names CAB27, CALB1, Calbindin, Calbindin D28, D-28K, Vitamin D-dependent calcium-binding protein, avian-type, CALB
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24°
About Each murine monoclonal anibody has his own affinity specific for the clone, Mouse monoclonal antibodies are purified protein A or G and can be conjugated to FITC for flow cytometry or FACS and can be of different isotypes, Monoclonals of this antigen are available in different clones
Gene targetCalbindin 1 (AF2E5) Monoclonal
Short nameCalbindin 1 (AF2E5) Monoclonal Antibody
Technique Monoclonals or monoclonal antibodies, antibodies against human proteins, antibodies for, Antibody
Alternative nameCalbindin 1 (AF2E5) monoclonal (Antibody to)
Alternative techniqueantibodies

Subscribe to our Newsletter